Mostrando resultados 135 a 154 de 215
< Anterior
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | 2017 | ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA | Talamillo, Ana; Grande, Lara; Ruiz Ontañón, Patricia; Velásquez, Carlos; Mollinedo, Pilar; Aznar, Ángela; Esparís-Ogando, Azucena CSIC ORCID ; López-López, Carlos; Lafita, M. Carmen CSIC ORCID; Berciano, María T.; Montero, Juan A.; Vázquez-Barquero, Alfonso; Segura, Víctor; Villagra, Nuria T.; Pandiella, Atanasio CSIC ORCID CVN ; Lafarga, Miguel; León, Javier CSIC ORCID CVN; Martínez-Climent, José Ángel; Sanz-Moreno, Victoria; Fernández-Luna, J. L. | artículo |
| closedAccess |  | 2011 | Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs | Martínez-López, Joaquín; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| closedAccess |  | 2011 | Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer | Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2005 | Overexpression of RasN17 fails to neutralize endogenous ras in MCF7 breast cancer cells | Yuste, Laura CSIC; Esparís-Ogando, Azucena CSIC ORCID ; Santos de Dios, Eugenio CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2011 | P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer | Montero, Juan Carlos CSIC ORCID; Seoane, Samuel CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2019 | Paclitaxel-trastuzumab mixed nanovehicle to target HER2-overexpressing tumors | Nieto, Celia; Centa, Ariana; Rodríguez-Rodríguez, Jesús A.; Pandiella, Atanasio CSIC ORCID CVN ; Martín del Valle, Eva María | artículo |
| closedAccess |  | 2020 | PDCD4 limits prooncogenic neuregulin-ErbB signaling | Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 29-jul-2010 | Personalized therapies in the cancer "omics" era | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2020 | Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer | Corrales-Sánchez, Verónica; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2015 | Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors | Serrano-Heras, Gemma CSIC ORCID; Cuenca-López, María D.; Montero, Juan Carlos CSIC ORCID; Morales, Jorge C.; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 30-abr-2014 | Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling | Cuenca-López, María D.; Montero, Juan Carlos CSIC ORCID; Morales, Jorge C.; Prat, Aleix; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| closedAccess |  | 2013 | Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells | Montero, Juan Carlos CSIC ORCID; Seoane, Samuel CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2013 | Potent antimyeloma activity of a novel ERK5/CDK inhibitor | Álvarez-Fernández, Stela CSIC; Ortiz-Ruiz, María Jesús CSIC; Parrott, Tracy; Zaknoen, Sara; Ocio, Enrique M. CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Burrows, Francis J.; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 15-sep-2021 | Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer | Guardia, Cristina; Bianchini, Giampaolo; Arpí, Oriol; Menendez, Silvia; Casadevall, David; Galbardi, Barbara; Dugo, Matteo; Servitja, Sonia; Montero, Juan Carlos CSIC ORCID; Soria-Jiménez, Luis; Sabbaghi, Mohammad A.; Peña, Raúl; Madoz-Gúrpide, Juan CSIC ORCID; Lloveras, Belén; Lluch, Ana; Eroles, Pilar; Arribas, Joaquín; Pandiella, Atanasio CSIC ORCID CVN ; Gianni, Luca; Rojo, Federico; Rovira, Ana; Albanell, Joan | artículo |
| closedAccess |  | 2011 | Preclinical development of molecular-targeted agents for cancer | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2012 | Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: Therapeutic implications | Montero, Juan Carlos CSIC ORCID; Chen, Xi CSIC; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2014 | Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis | Seruga, Bostjan; Amir, Eitan; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2019 | Prognostic value of Lymphocyte-Activation Gene 3 (LAG3) in cancer: A meta-analysis | Saleh, Ramy R.; Peinado, Paloma; Fuentes-Antrás, Jesús; Pérez-Segura, Pedro; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | artículo |
| openAccess |  | 19-ene-2022 | Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis | Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | artículo |
| openAccess |  | 2020 | Proteolysis targeting chimeras (PROTACs) in cancer therapy | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo de revisión |
